Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•09/10/2026•16:05 ET
0
Key Highlights
- ➤Pulse Biosciences granted inducement options covering 5,700 shares to two new employees
- ➤Options carry a $49.98 exercise price, matching the October 8 closing price
- ➤Awards vest annually over four years, subject to continued employment
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were approved and issued on October 8, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).
Get started
Create a free account to read the full story.